Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The implications of clonal genome evolution for cancer medicine.

Literature DB >> 23445095

The implications of clonal genome evolution for cancer medicine.

Samuel Aparicio¹, Carlos Caldas.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents
DNA

Year: 2013 PMID： 23445095 DOI： 10.1056/NEJMra1204892

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

145 in total

1. Pediatric cancer genomics, a play rather than a portrait.

Authors: Vijay Ramaswamy; Michael D Taylor
Journal: Nat Genet Date: 2015-08 Impact factor: 38.330

Review 2. Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Authors: Leticia De Mattos-Arruda; Javier Cortes; Libero Santarpia; Ana Vivancos; Josep Tabernero; Jorge S Reis-Filho; Joan Seoane
Journal: Nat Rev Clin Oncol Date: 2013-05-28 Impact factor: 66.675

Review 3. Leukaemia 'firsts' in cancer research and treatment.

Authors: Mel Greaves
Journal: Nat Rev Cancer Date: 2016-03 Impact factor: 60.716

4. Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.

Authors: Johanna Oltmann; Kerstin Heselmeyer-Haddad; Leanora S Hernandez; Rüdiger Meyer; Irianna Torres; Yue Hu; Natalie Doberstein; J Keith Killian; David Petersen; Yuelin Jack Zhu; Daniel C Edelman; Paul S Meltzer; Russell Schwartz; E Michael Gertz; Alejandro A Schäffer; Gert Auer; Jens K Habermann; Thomas Ried
Journal: Genes Chromosomes Cancer Date: 2018-01-09 Impact factor: 5.006

5. Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.

Authors: Caroline S Fox; Jennifer L Hall; Donna K Arnett; Euan A Ashley; Christian Delles; Mary B Engler; Mason W Freeman; Julie A Johnson; David E Lanfear; Stephen B Liggett; Aldons J Lusis; Joseph Loscalzo; Calum A MacRae; Kiran Musunuru; L Kristin Newby; Christopher J O'Donnell; Stephen S Rich; Andre Terzic
Journal: Circulation Date: 2015-04-16 Impact factor: 29.690

The implications of clonal genome evolution for cancer medicine.

1. Pediatric cancer genomics, a play rather than a portrait.

Review 2. Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Review 3. Leukaemia 'firsts' in cancer research and treatment.

4. Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.

5. Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.

6. Scalable whole-genome single-cell library preparation without preamplification.

Review 7. Evolutionary scalpels for dissecting tumor ecosystems.

Review 8. Characterizing the Cancer Genome in Blood.

9. Tumour heterogeneity in the clinic.

Review 10. High-throughput gene expression and mutation profiling: current methods and future perspectives.